← Companies|Natl Taiwan Univ Hosp
Na

Natl Taiwan Univ Hosp

NPTaipei TWFounded 18956,000 employees
Private CapacadPrivateOncology
Platform: Teaching Hosp
Market Cap
N/A
All Drugs
6
Clinical Trials
6
Failed / Terminated
0
FDA Approved
1
Drug Pipeline (6 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
NAT-IIT-496NAT-IIT-496NDA/BLA1Cell TherapyTROP-2SGLT2iSLE
NAT-IIT-589NAT-IIT-589Phase 1/21siRNACDK4/6STINGagOCD
NAT-IIT-836NAT-IIT-836NDA/BLA1ASOMALT1CGRPantAsthma
NAT-IIT-338NAT-IIT-338Approved1DegraderBTKJAK1/2iCRC
NAT-IIT-326NAT-IIT-326Phase 1/21Fusion ProteinPARPFcRniMS
NAT-IIT-211NAT-IIT-211Phase 31Small MoleculeAuroraAEGFRiHemophilia A
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (6)
2025-07-26
NAT-IIT-836 Ph3 Readout
Asthma
Past
2025-11-11
NAT-IIT-211 Conference
Hemophilia A
Past
2028-07-07
NAT-IIT-496 Ph3 Readout
SLE
Ph3 Readout
2029-11-28
NAT-IIT-338 Ph3 Readout
CRC
Ph3 Readout
2030-04-13
NAT-IIT-589 Ph2 Data
OCD
Ph2 Data
2030-06-17
NAT-IIT-326 Ph2 Data
MS
Ph2 Data